Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy
ClinicalTrials.gov study NCT06552572. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy
ClinicalTrials.gov study NCT05640713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cell
ClinicalTrials.gov study NCT07042438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
ClinicalTrials.gov study NCT02623075. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04011293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies
ClinicalTrials.gov study NCT04888338. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
ClinicalTrials.gov study NCT06251544. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01716364. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
ClinicalTrials.gov study NCT02932956. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)
ClinicalTrials.gov study NCT00699712. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
ClinicalTrials.gov study NCT01019876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
ClinicalTrials.gov study NCT06043323. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT06751134. IPD Sharing: Not stated. Countries: 1. Publications: 0.
3rd Generation GD-2 Chimeric Antigen Receptor and ICaspase Suicide Safety Switch, Neuroblastoma, GRAIN
ClinicalTrials.gov study NCT01822652. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
ClinicalTrials.gov study NCT06345027. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B
ClinicalTrials.gov study NCT07259070. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
ClinicalTrials.gov study NCT06227026. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)
ClinicalTrials.gov study NCT04034446. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05420493. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children
ClinicalTrials.gov study NCT06904729. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.